Revertant mosaicism by somatic reversion of inherited mutations has been described for a number of genetic diseases. Several mechanisms can underlie this reversion process, such as gene conversion, crossing-over, true back mutation, and secondsite mutation. Here, we report the occurrence of multiple corrections in two unrelated probands with revertant mosaicism of non-Herlitz junctional epidermolysis bullosa, an autosomal recessive genodermatosis due to mutations in the COL17A1 gene.
Introduction
Genetic mosaicism is defined as the presence of two or more genetically distinct populations of cells that differ from each other in their DNA but are derived from a single zygote within one individual [1] . If an inherited disease-causing mutation is corrected in a somatic cell by means of a second genetic event, gene function can be completely or partially restored in these so-called revertant cells. Correction of a stem cell will lead, in this case, to life-long repair. This phenomenon of "natural gene therapy" has led to revertant mosaicism in several human inherited diseases, including Among the reported second-site mutations are a readingframe-restoring insert of 2 bp and a frameshift mutation that nullifies a dominant-negative allele [7, 8] . Despite this apparent range of reversion mechanisms available to the human body, only a single type has been found in each individual patient, apart from one very recently described individual with tyrosinemia type I [9] . This suggests either that such in vivo reversion is a one-time single event or that a particular mechanism is preferred for correction of a specific type of mutation.
Generalized atrophic benign epidermolysis bullosa (GABEB [MIM 226650])-which is the generalized variant of non-Herlitz junctional epidermolysis bullosa (nH-JEB),
an autosomal recessive bullous genodermatosis-is characterized by generalized skin blistering from birth onward, dental anomalies, universal alopecia, and nail dystrophy [10, 11] . The underlying defect is mutation of the COL17A1 gene, which encodes the 180-kDa type XVII collagen [12, 13] (human COL17A1 mRNA sequence:
GenBank accession number NM_000494; human COL17A1 transcript sequence:
GenBank accession number NP_000485). The COL17A1 gene spans 52 kb of the genome on chromosome 10 and encompasses 56 exons that range in size from 27 to 390 bp [14, 15] . Type XVII collagen is a glycosylated type II transmembrane protein of 1,497 aa. Its COOH-terminal extracellular part, comprising approximately twothirds of the protein, contains 15 interrupted collagenous domains, designated "COL1"-"COL15" [16] . The protein is expressed in basal epithelial cells and is part of the hemidesmosome, a critical structure for attachment of basal epithelial cells 42 to the underlying matrix. Although type XVII collagen almost certainly has signaltransduction properties, its main function is to act as a transmembrane link in the molecular chains that anchor the cytoskeleton of the basal keratinocytes to the basement membrane. Previously, we demonstrated that the in vivo reversion in keratinocytes cultured from a revertant skin patch of the hand of a patient with GABEB was the result of mitotic gene conversion, the nonreciprocal transfer from one chromosome to another [6] . Here, we expand these studies by analyzing separate revertant patches within individual patients. Using laser dissection microscopy (LDM), we now find that different correcting COL17A1 mutations are responsible for the restoration of type XVII collagen expression in distinct cell clusters within the same patient.
Materials and Methods

Biopsy sites
For immunofluorescence (IF) microscopy, six 4-mm punch-biopsy specimens were obtained and were snap frozen: two from clinically unaffected skin of the right middle finger of a 75-year-old man (patient EB 093-01), three from nonlesional affected skin of his right upper arm, and one from nonlesional affected skin of his shoulder.
Biopsy specimens from unaffected skin of the left forearm and the right upper arm of a 45-year-old woman (patient EB 026-01) were also analyzed. In addition to specimens from these biopsy locations described by Jonkman et al [6] , another biopsy specimen was obtained from unaffected skin of the left ankle.
For electron microscopy, three 2-mm punch-biopsy specimens were obtained from patient EB 093-01: two from lesional affected skin of the right upper arm and one from unaffected skin of the right middle finger.
Immunomorphological analysis of skin and cultured keratinocytes
Details of IF microscopy, electron microscopy, and keratinocyte culturing have been described extensively elsewhere [12] . For detection of type XVII collagen, the following monoclonal antibodies were used: 1A8C, specific to the endodomain (epitope located between amino acids 155 and 160), and 1D1 and 233, both specific to the ectodomain (1D1 epitope located between amino acids 1357 and 1387; 233 epitope located between amino acids 1118 and 1143) (all were gifts from Dr. K.
Owaribe [Nagoya, Japan]) [17] . The Alexa488-conjugated goat anti-mouse IgG antibody (Brunschwig Molecular Probes) was used for a secondary step.
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Mutation detection strategy
The detection of mutations in the genomic DNA of patient EB 026-01 has been published previously [6] . For identification of the mutations in the DNA of patient EB 093-01, all 56 exons of COL17A1 were amplified using the primers described by Gatalica et al [15] and subsequently sequenced (GenBank accession numbers U76564-U76604), except the primer for exon 46. For exon 46, we used instead the sense primer 5'-GTGCTTCAGGTCACCTCCGT-3' and the antisense primer 5'-ACGAGGAGATGAGGCTCTGG-3'. Unfortunately, genomic DNA from the parents or from other first-degree relatives of patient EB 093-01 was no longer available.
Verification of mutations
Verification of the 1706delA mutation in exon 18 and the 3781C→T mutation in exon 51 by restriction analysis was done as described elsewhere [6] . The 4424-5insC mutation in exon 54 does not create or abolish a restriction site and was therefore verified by repeated sequencing.
LDM
For DNA recovery by LDM, skin cryosections of 4 µm were mounted on 1.35-µm-thin polyethylene-naphthalene membranes attached to normal 1-mm slides and were stained with monoclonal antibody 1D1 by use of the same staining procedure described elsewhere [6] , except for the absence of the bisbenzimid step in the protocol. For selection of the sites of epidermal basement membrane that stained either positive or negative for type XVII collagen, IF images were acquired using a digital camera and were processed with P.A.L.M. RoboSoftware 1.2 (P.A.L.M.
Microlaser Technology AG). Cells were dissected using the Laser Robot Microbeam System (P.A.L.M. Microlaser Technology AG). Dissected areas were directly collected in the cap of a 0.2-ml thin-wall reaction tube with a flat cap containing 30 µl of onetime PCR buffer (Amersham Pharmacia Biotech) and 1 µl of proteinase K (Invitrogen).
For RNA recovery, staining with monoclonal antibody 1D1 was omitted because we noted that, after staining, almost all the RNA was lost. Therefore, serial cryosections were prepared, and every fourth section was mapped by IF microscopy. On the basis of the staining pattern of these sections, the epidermis of five to seven skin sections was collected in the cap of a 0.5-ml P.A.L.M. tube (P.A.L.M. Microlaser Technology) that contained 30 µl of lysis buffer (Stratagene Europe) and was used for RNA isolation.
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DNA isolation of LDM samples
Microdissected epidermis from ~200 cells was collected in a 0.2-ml reaction tube.
During digestion by proteinase K, the tubes remained inverted for 60 min at 55°C; subsequent heating to 98°C for 15 min inactivated the proteinase K. The final aliquots were used for PCR.
Cytospin
To analyze DNA of cultured revertant keratinocytes from the hand of patient EB 026-01, cytospin was conducted; 1.35-µm-thin polyethylene-naphthalene membranes attached to normal 1-mm slides (P.A.L.M. Microlaser Technology AG) were coated with 10 µl of polylysine and were dried for 30 min at 37°C. Cytospin was performed with a number of cells sufficient to allow LDM isolation of reverted cells. The glass slides were then dried. Subsequently, the cells were fixed for 10 min at room temperature by use of 1% formaldehyde in phosphate-buffered saline, washed, and incubated for 5 min in 0.5% Triton X-100 in phosphate-buffered saline. The cells were stained with monoclonal 1A8C, as described elsewhere [12] , and were then used for LDM.
RNA isolation
Tubes were centrifuged for 1 min at 10,000 g, and 70 µl of lysis buffer containing 0.7 µl of β-mercaptoethanol was added. Total RNA was then prepared using the Stratagene RNA nanoprep kit (Stratagene), for a final volume of 10 µl.
cDNA synthesis
For cDNA synthesis, 1 µl of 300-ng/µl random primers (Invitrogen) and 1 µl of 10 mM dNTP mix (Fermentas) were added to 10 µl of total RNA and were incubated for 5 min at 65°C. The tubes were then immediately put on ice, and 4 µl of 5 × First Strand buffer, 2 µl of 0.1 M dithiothreitol, and 1 µl of 10-units/µl RNase Inhibitor Cloned (all Invitrogen) were added. Incubation for 10 min at 25°C was followed by 2 min at 42°C. Finally, 1 µl of 1-unit/µl Superscript II RNase H -Reverse Transcriptase (Invitrogen) was added. Tubes were incubated for 50 min at 42°C, followed by 15 min at 70°C to inactivate the enzyme. For PCR, 10 µl of cDNA was used in a total volume of 50 µl.
Identification of mutations in LDM samples
For detection of mutations in LDM-isolated DNA, we used nested PCR. For the Correcting COL17A1 mutations in JEB 45 second PCR, 1 µl of the first PCR product was used. PCR cycling conditions were 5 min at 94°C, followed by 30 cycles at 94°C for 45 s, 55°C for 45 s, and 72°C for 1 min and 30 s and a final extension at 72°C for 7 min. Water, instead of DNA, was used as a negative control. Primer sequences and sizes of PCR products are listed in table 1. After PCR, aliquots of 14 µl were examined using 4% agarose gel electrophoresis.
Also, the cDNA samples from dissected cells were subjected to nested PCR. All primers were designed in such a way that the PCR product contained sequences from multiple exons. Primer sequences for amplification of COL17A1 cDNA and sizes of PCR products are listed in table 2. All PCRs were repeated with templates from at least three separate nucleic-acid isolations obtained by LDM, and all products were sequenced. The numbers 1 and 2 refer to the first PCR and the second/nested PCR respectively. To investigate the possible presence of alternative spliced mRNA transcripts due to the splice-site mutation in intron 54, 4463-1G→A, primers were developed with the sense primer located in exon 52 and the antisense after exon 56.
Identification of SNPs in LDM samples
For the identification of SNPs, nested PCRs and, in a few cases, seminested PCRs were performed. Primer sequences and sizes of PCR products for 1822+14T/C in intron 19 (dbSNP identifier rs17821926), 2268+120T/C in intron 28 [15] , 2700T/C in exon 37 (rs4918079), 2988A/C in exon 43 (rs2296219), and 4214A/G in exon 52 (rs17116350) are listed in table 1. Like the identification of the mutations in LDM samples, all PCRs for SNPs were repeated with templates from at least three separate nucleic-acid isolations obtained by LDM, and products were sequenced afterward.
Microsatellite analysis
To detect possible crossovers in the DNA of patient EB 026-01, the alleles flanking the COL17A1 gene on chromosome 10q24.3 were analyzed using microsatellite polymorphisms [18] . The flanking markers D10S603 and D10S597 (8 cM apart) were used. D10S566 and D10S554 were not analyzed, since these were homozygous in the patient's DNA and were thus not informative [6] . For analysis of the microsatellites D10S603 and D10S597, we also used nested PCRs, because of the small amount of LDM-isolated DNA. Primers for the first PCR for D10S603 were sense primer 5'-GCTGGATTATCTCGGTAACC-3' and antisense primer 5'-GTTCATCTCCCAAGGCAATG-3'. Primers for the first PCR for D10S597 were sense primer 5'-AGAAGAGGAAGGCTGTCAGA-3' and antisense primer 5'-GCCACAAGACTTGTGTTTGC-3'. Primers for the second PCRs were as described elsewhere [18] .
Cloning
The nested PCR product of exon 51 from the ankle specimen of patient EB 026-01 was cloned into the pCR4-TOPO (Invitrogen) vector according to manufacturer's protocol to investigate whether the mutations 3781C→T and 3782G→C were located on the same chromosome. Five clones were selected and sequenced.
Results
Patient EB 093-01
The first proband was a 75-year-old Dutch male who had the GABEB variant of nH-JEB. Since birth, he had generalized blistering after minor trauma, without evidence of scarring or milia formation. He also had universal alopecia, small rudimentary nails, and enamel hypoplasia. His nonconsanguineous parents and his sister were Correcting COL17A1 mutations in JEB 47 healthy. On clinical examination, he presented with a circular patch of clinically unaffected skin, ~2 cm 2 on his right middle finger, which tolerated the wearing of his wedding ring ( fig. 1A ). This skin looked perfectly healthy and sturdy, and no blisters had ever occurred there. The size of this unaffected area had remained stable throughout his life. This clinical presentation was suggestive of revertant mosaicism, since the nH-JEB symptoms were generalized, with the rare exception of the patch on the middle finger. Two biopsy specimens of the unaffected skin of the right middle finger, three of the nonlesional affected skin of the right upper arm, and one of the lesional affected skin of the shoulder were studied using IF microscopy.
Staining with monoclonal antibodies against type XVII collagen showed a mosaic pattern in both biopsy specimens of the middle finger. The epidermal basement membrane stained positive for type XVII collagen, showing the same intensity as normal human control skin, with one interruption of ~150 µm that was not stained, which resembled 10% of the basal cells of this biopsy specimen ( fig. 1B and 1C ). In contrast, the specimen from the nonlesional affected skin of the shoulder and two specimens from the upper arm were completely negative for type XVII collagen.
However, the third upper-arm biopsy specimen of affected skin demonstrated an interruption in the dermal-epidermal junction: ~500 µm (25% of the basal cells) of type XVII collagen-expressing cells ( fig. 1D ).
Electron microscopy of gently rubbed affected skin showed a cleavage plane through the lamina lucida, thereby confirming the JEB diagnosis (data not shown).
In nonlesional affected skin, hemidesmosomes were low in number (<5 per 40 µm of basement membrane vs. 49-98 per 40 µm in normal control skin) and appeared to be hypoplastic ( fig. 2A and 2C ). The unaffected skin of the middle finger showed a larger number of hemidesmosomes (41 per 40 µm) than the affected skin ( fig. 2B and 2D), and these hemidesmosomes were normal in shape.
To determine mutations in COL17A1, DNA was isolated from peripheral blood lymphocytes and was sequenced with intron primers [15] . Two heterozygous mutations were identified: a nonsense mutation in exon 51, 3781C→T (R1226X),
and an insertion of a C in exon 54 between nucleotides 4424 and 4425. This insC mutation caused a frameshift, resulting in a novel sequence beginning at amino acid To study the cells re-expressing type XVII collagen in the mosaic biopsy specimens, we needed a technique that could isolate separately the different cell populations:
type XVII collagen-negative keratinocytes and type XVII collagen-positive keratinocytes. LDM allows for recovery of DNA and RNA directly from biopsy material and eliminates the necessity of culturing the keratinocytes with the risk of selection in vitro. Furthermore, in vivo spliced mRNA is analyzed, which excludes possible deviant splicing due to culturing conditions, as was demonstrated for the hemidesmosomal protein integrin α6β4 [19] .
Interestingly, the type XVII collagen-positive cells of the middle finger, isolated by LDM, carried an additional mutation, 4463-1G→A, in the intron 54-exon 55 border, on the same allele as the 4424-5insC mutation ( fig. 3B ). This second-site 50 mutation changes the consensus sequence of the 3' splice site, which ends with the invariant AG. In this case, the invariant G is replaced with an A, and, since exon 55 starts with a G, a possible new splice site is created 1 nt further downstream.
Subsequently, RNA was isolated from epidermis that stained positive, and this RNA indeed showed a deletion of G at position 4463 ( fig. 4A and 4B ). This deletion restores the frameshift caused by the 4424-5insC mutation, beginning at amino acid 1453, and results in a protein of correct size but with a stretch of 13 different amino acids (GQKGEMGTPGPKG→WAKRRDGHSRTQS) in the first collagenous domain (COL1). Since the patient's middle finger displays healthy skin, this protein is functional enough to restore normal skin strength, which also implies that, despite the disruption of the Gly-X-Y collagen motif, the changed amino acids are not essential for interactions with other hemidesmosomal proteins.
Unexpectedly, the analysis of the revertant cells of the upper arm showed something completely different. The frameshift caused by the 4424-5insC mutation was not corrected, because the restoring mutation 4463-1G→A was lacking. However, the 3781C→T mutation on the other allele was missing, thus revealing another reversion mechanism in these keratinocytes ( fig. 3C ). The absence of this nonsense 
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Patient EB 026-01
The second proband, a 45-year-old female with revertant mosaicism, who is compound heterozygous for a paternal mutation in exon 51, 3781C→T (the same mutation as in patient EB 093-01), and who has a maternal deletion in exon 18, 1706delA, has been described elsewhere [6] . She had unaffected nonconsanguineous parents and the same constellation of symptoms as patient EB 093-01, which classified her condition too as the GABEB variant of JEB. About 10% of her total body surface was covered with revertant skin. Extensive photo documentation from 1994 and 2005 showed the stability of the patches and excluded the possibility of expansion of the clinically unaffected skin ( fig. 5A-5F ). We demonstrated elsewhere that, in cultured revertant keratinocytes derived from the dorsum of the patient's left hand, a gene conversion had occurred, resulting in the loss of the maternal deletion [6] . For the current study, with the intriguing results of patient EB 093-01 in mind and with the possibility of directly analyzing stored skin-biopsy specimens by use of the LDM technique, we reinvestigated this patient. Besides the patches of unaffected skin on her arms and hands, the patient indicated another unaffected patch on the ankle, which is also visible in photographs taken in 1969. IF microscopy showed that, in the ankle specimen, in contrast to the interrupted pattern in the biopsy specimens of the forearm and the right upper arm (50% of cells positive for type XVII collagen), the whole epidermal basement membrane stained positive for type XVII collagen, with a similar intensity as that of normal human control skin. Unexpectedly, in these LDM-isolated, type XVII collagen-positive keratinocytes from the ankle, both of the inherited mutations, 1706delA and 3781C→T, were still present, but a second mutation was detected on the 3781C→T allele. At position 3782, a transversion from G to C (3782G→C) had occurred, 1 nt behind the 3781C→T mutation ( fig. 3E ).
This compensatory mutation results in the replacement of the nonsense mutation at position 1226 to a missense mutation (R1226X→R1226S). Figure 4C shows that the RNA isolated from the same cells originates mainly from the corrected allele. The 1706delA allele hardly contributes, most likely because of degradation by nonsense mediated RNA decay, a conserved posttranscriptional mechanism that prevents the synthesis of truncated proteins that could be deleterious to the cell. Considering the absence of blister formation after hard rubbing of the skin on the ankle and the IF staining with the intensity of normal control skin, we conclude that the produced type XVII collagen with one altered residue is functional.
A third reversion event was found in the biopsy specimens of the forearm and upper arm. Like the revertant skin of the hand, the LDM-isolated, type XVII collagen-positive keratinocytes of both specimens showed loss of the maternal 1706delA mutation ( fig. 3F ). Also, data from the SNP and microsatellite analysis with D10S597, on the telomeric side of the COL17A1 gene, and D10S603, on the centromeric side of COL17A1, were similar to the data for the hand. However, the SNP in intron 19 (1822+14C/T) showed a loss of heterozygosity (table 3) 
NOTE.-SNPs within the COL17A1 gene are indicated by nucleotides. The pathogenic mutations are underlined, and the compensatory second-site mutations are in bold italics. * Data for the hand were obtained from Jonkman et al [6] .
Discussion
This study reveals that, in two compound heterozygous, unrelated probands, multiple distinct somatic reversions of pathogenic COL17A1 mutations have occurred that clinically result in discrete patches of functionally restored skin. In the patients described, both of the inherited mutations, paternal as well as maternal, reverted at least once by different reversion events ( fig. 6 ).
Despite the low number of reversions described in humans, three cases-one case of FA and two cases of WAS-were reported in which patients with revertant mosaicism who were from the same family independently developed the same compensatory second-site mutation [21] [22] [23] . Because of the occurrence of the same correcting mutation in the siblings, it was suggested that these secondsite mutations resulted from a specific molecular mechanism, rather than from a randomized process. Waisfisz et al [21] showed, in two brothers, the functional correction of the inherited 1749T→G mutation in the FANCC gene by the 1748C→T nucleotide change, creating a cysteine codon (L496C) instead of an arginine codon (L496R). This transition was assumed to be mediated by methylation. In addition, Wada et al [22, 23] implied that DNA polymerase slippage was the cause of the compensatory deletions in two of their families. In one family, the function of the WAS protein was restored in two brothers by the same second-site mutation, a deletion of 19 bp that included the original 1305insC mutation in the WASP gene [22] . In the other family, DNA polymerase slippage was also hypothesized to underlie the inherited mutation, a 6-bp sequence insertion, as well as the correction, the deletion of the same 6-bp sequence [23] . Our data are fascinatingly different. The mutation 3781C→T, present in both patients, reverted in two different ways. In patient EB 093-01, the reversion was most likely a true back mutation, whereas, in patient EB 026-01, the second-site mutation 3782G→C resulted in a serine codon (R1226S) instead of a stop codon (R1226X). In contrast to the described siblings with FA and WAS, our patients are unrelated. Thus, if correction mutations result from a specific molecular mechanism, then other factors also influence the preference for a certain reversion mechanism.
Figure 6
Multiple reversion mutations in patients EB 093-01 and EB 026-01. In mitosis in a diploid cell after DNA replication and normal segregation, each daughter cell obtains one chromosome from the father and one from the mother. Homologous chromosomes carry the paternal or maternal mutation in the COL17A1 gene (black bars). Cells devoid of the protein are depicted in white, and cells with a revertant phenotype are depicted in gray. The dots in the picture refer to the biopsy sites, and the accompanying drawings show the underlying mechanism of the reverse mutation of that skin patch. Although the type XVII collagen produced in the cells with a second-site mutation (white bars) was different from the wildtype protein, the skin displayed a revertant phenotype.
In patient EB 026-01, gene conversion was demonstrated as the correcting mechanism for the 1706delA mutation in three of the four biopsy specimens studied. The specimens of the left forearm and right upper arm, although located far apart and in separate clusters, had the same DNA pattern. Therefore, they could have originated either from a single early correction event that took place before lateralization of the embryo or from two independent but identical correction events.
Since no other heterozygous SNPs were noticed before exon 18 or between intron 19 and intron 28, the answer remains elusive. It might be that, in this patient, gene conversion around the exon 18 mutation is favored as the correcting mechanism because 1706delA is located close to the COL17A1-CA1 microsatellite in intron 
Multiple correcting mutations in other hereditary diseases
Recently, a patient with revertant mosaicism of hereditary tyrosinemia was described who had multiple reversion mutations in the FAH gene in different liver nodules [9] . This patient was compound heterozygous for a missense mutation in exon 12 (1009G→A; G337S) and a splice-site mutation in intron 12 (IVS12+5G→A). Three immunopositive liver nodules were investigated. In one nodule, a compensatory mutation (1061C→A) 6 bp upstream of the inherited splice-site mutation was detected, whereas, in the other two nodules, this splice-site mutation reverted to the wild-type sequence. True mutation reversion of the FAH gene most often underlies the restoration of the enzymatic activity. However, in this patient, besides true mutation reversion, a second-site mutation that restored the 5' splice site of exon 12 was also identified. The presence of multiple correcting mutations in patients with EB and tyrosinemia type I suggests that, in the future, various mutations within one patient will be detected for other genetic diseases also.
Random mutagenesis versus directed mutagenesis
One other patient with revertant nH-JEB with correction of COL17A1 mutation has been described, although, in this patient, no regions of clinically unaffected 58 skin were present [7] . Darling et al [7] found, among three biopsy specimens taken from nonlesional affected skin, two with focal expression of type XVII collagen.
Keratinocytes independently grown from a third site also demonstrated restored protein synthesis. LDM analysis of one biopsy specimen revealed correction of the homozygous 4003delTC deletion by a frame-restoring insertion of two Gs, 4080insGG, in one chromosome. The resulting type XVII collagen molecule was of normal length but had a stretch of 25 altered amino acids. Thus, at the moment, three patients with mosaic nH-JEB have been described from among ~3,000 patients with nH-JEB worldwide, established on the basis of the prevalence of 0.5 per million persons observed in the United States [25] . Most likely, the number of patients with mosaicism is larger than that reported, since revertant keratinocytes can be present in affected skin and therefore will often remain unnoticed. An interesting question, to which the answer is yet unclear, is whether these reversions are occurring with a higher frequency than would be expected by chance. Recently, in the Arabidopsis plant, it was shown that the genetic restoration events that took place occurred with a higher frequency, in the order of a few percent, than could be explained by random mutagenesis [26] . Those authors postulated that the precise reversions are the result of a template-directed process that makes use of an ancestral RNAsequence cache that comes from previous generations. Such a mechanism, if we assume that it would be present in other eukaryotes as well, would not, however, explain the presence of the second-site mutations detected in our patients.
Patient EB 026-01 has one patch on her left hand that includes both the middle finger and the pointing finger ( fig. 5A and 5B). The reversion event that occurred in these keratinocytes should have taken place before the evolvement of the fingers, in the 8th week of pregnancy. If we assume that the fetus, at the time of the reversion event, was not >2.5 cm in length and had a similar skin constitution 
Functional restoration of the skin
Our patients demonstrate that reversion of pathogenic COL17A1 mutations, either to the wild type or to a slightly altered sequence, may lead to functionally healthy skin. To obtain this restoration, only one corrected allele is needed, since nH-JEB is a recessive disease and heterozygous carriers display a normal skin phenotype.
Furthermore, not all cells need to be reverted, as shown by the presence of interruptions in the staining of the epidermal basement membrane in the biopsy specimens of unaffected skin. However, these type XVII collagen-positive cells have to be present over a sufficiently large area. In patient EB 093-01, we found, in one specimen, wild-type expression of type XVII collagen over ~0.25 mm 2 , but this area was obviously too small.
The earlier that reversion takes place in the embryonic development in vivo, the more likely that revertant descendant stem cells may finally spread as larger clusters and the more beneficial for clinical severity this may be. Because the correcting mutations were undetectable in leukocytes derived from mesoderm, all reversion events in the described patients took place after the development of the threelayered embryo in the 2nd week. Although the phylloid mosaic pattern of patient EB 026-01 was bilaterally distributed, the correcting mutations could have taken place after lateralization of the embryo, because the revertant patches were not symmetrical and the reversion events were caused by different mechanisms. The later the reversion occurred during embryogenesis, the smaller the patch. It may be that the focal correction observed in the upper arm of patient EB 093-01 and the focal correction observed by Darling et al [7] reflect such late-embryonic events.
The somatic mutations in our patients occurred in areas of the skin exposed to sunlight-in particular, the ankle and the extensor surfaces of arms and handsand, for this reason, it was suggested that the acquired somatic mutations could have been environmentally induced early in life. Ultraviolet irradiation may cause two adjacent pyrimidine residues (C or T) to form a dimer. If not repaired, mutations in the form of C→T and CC→TT transitions can be introduced in the DNA sequence.
In our patients, three mutations were introduced: 3781T→C, 3782G→C, and 4463-1G→A. Since the formation of pyrimidine dimers and (6-4) photoproducts cannot result in a T→C or G→C nucleotide change, the involvement of ultraviolet irradiation can be excluded for the 3781T→C and 3782G→C mutations. In the case of the 4463-1G→A mutation, a possible effect of ultraviolet irradiation is not ruled out, because the DNA sequence on the opposite strand contains adjacent pyrimidine residues.
Stability of the healthy skin patches
Both our patients claimed that their patches of healthy skin had been there as long as they could remember and that they had not changed in size. Extensive photo documentation of patient EB 026-01 in 1969, 1994, and 2005 arrest and apoptosis [34, 35] . Furthermore, in WAS, X-linked SCID, and adenosine deaminase deficiency, a selective growth advantage over their protein-deficient counterparts has also been observed for revertant lymphocytes [22, 36, 37] .
In summary, we demonstrate that 2 of 11 Dutch COL17A1 patients (chapter 6) have multiple correcting mutations in COL17A1. Given this observed high frequency, the occurrence of more than one reversion event per individual, and the observation that reversion clusters may be too small to fully restore function, it is conceivable that reversions have often been overlooked in other patients. Studying this "natural gene therapy" will benefit experimental research of gene and cell therapy and will bring successful therapies for genetic diseases closer to actuality.
